The global Intracranial Pressure (ICP) Monitoring Market is estimated at approximately $1.73 billion in 2025. It is projected to reach nearly $3.54 billion by 2035, expanding at a compound annual growth rate (CAGR) of 7.42%. This growth is primarily fueled by the rising global incidence of traumatic brain injuries (TBIs), which account for nearly 38.6% of the market share in 2025, alongside a surge in cases of hydrocephalus and intracerebral hemorrhage.
In 2025, the Invasive Monitoring segment continues to lead the market, as neurosurgeons prioritize the high-fidelity data provided by intraventricular and intraparenchymal sensors in acute trauma settings. However, the market is gradually shifting as healthcare providers seek "minimally disruptive" ways to monitor the brain. The Epidural Sensor niche is currently the fastest-growing category, favored for its lower risk of infection and clinical complications compared to traditional ventricular catheters.
Geographically, North America remains the dominant region, commanding roughly 37.2% to 40% of the market share in 2025. This dominance is attributed to high healthcare expenditure and the concentration of key industry players like Medtronic and Integra LifeSciences. Meanwhile, the Asia-Pacific region is documented as the fastest-growing market through 2035, driven by a 9.5% CAGR and a high volume of road-traffic accidents in emerging economies like India and China.
People Also Ask:
What is the projected CAGR for the ICP monitoring market through 2035?
Which region holds the largest share of the intracranial pressure monitor market?
Why is invasive monitoring still the dominant technique in 2025?
